Results 31 to 40 of about 14,564 (155)

Detection of human cytomegalovirus cell‐free DNA in pregnant women with symptomatically infected fetuses: proof‐of‐concept study

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 470-477, April 2025.
ABSTRACT Objective To evaluate the presence and levels of cytomegalovirus (CMV) cell‐free DNA (cfDNA) fragments in women pregnant with a fetus with symptomatic congenital CMV (cCMV). Methods The study comprised nine women whose fetuses were diagnosed with cCMV between June 2019 and July 2024 at 20 + 4 to 34 + 1 weeks' gestation (n = 8) or neonatally (n 
B. H. W. Faas, T. Meuleman, G. Astuti, A. Reuss, K. Stol, E. A. Sistermans, J. Linthorst, E. van Leeuwen, J. Rahamat‐Langendoen, F. A. Wilmink   +9 more
wiley   +1 more source

N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 447-455, April 2025.
ABSTRACT Objective A soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio cut‐off of 38 is currently considered optimal for ruling out pre‐eclampsia (PE); however, implementation of this ratio in clinical practice is limited.
M. N. Nan, C. Garrido‐Giménez, Á. Garcia‐Osuna, P. Garcia Manau, J. Ullmo, J. Mora, O. Sanchez‐Garcia, J. Platero, M. Cruz‐Lemini, E. Llurba, on behalf of the EuroPE working group, M. Vila‐Cortés, M. J. Pelegay, M. Ricart, B. Muñoz‐Abellana, X. Gabaldó Barrios   +15 more
wiley   +1 more source

Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 3, Page 303-310, March 2025.
ABSTRACT Objective Globally, one in four pregnant women is classified as overweight or obese, based on their prepregnancy body mass index (BMI). Obese pregnant women are at increased risk of adverse pregnancy outcomes and long‐term cardiovascular disease that occurs earlier in life.
M. Charakida, C. Chatzakis, L. A. Magee, A. Syngelaki, T. Mansukhani, P. von Dadelszen, K. H. Nicolaides   +6 more
wiley   +1 more source

Prediction of pre‐eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 2, Page 173-182, February 2025.
ABSTRACT Objectives To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre‐eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal ...
X. Wang, D. S. Sahota, L. Wong, L. Nguyen‐Hoang, Y. Chen, A. S. T. Tai, F. Liu, S. Ling Lau, A. P. W. Lee, L. C. Poon   +9 more
wiley   +1 more source

羊水过少胎盘血管铸型特点及与妊娠结局的关系 [PDF]

, 2011
目的分析羊水过少胎盘血管铸型特点,探讨其与妊娠结局的关系。方法采用血管铸型技术,铸型30例正常胎盘和35例羊水过少胎盘血管系统,总结两组的特点及妊娠结局。结果与正常妊娠胎盘比较,羊水过少组的胎盘静脉容量和动脉系统容量均较少 ...
黄秀敏, 张其清, 李娜, 胡庆中, 崔彬彬   +4 more
core  

Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine‐scar dehiscence

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 1, Page 85-93, January 2025.
ABSTRACT Objective Accurate differentiation between placenta accreta spectrum (PAS) and uterine‐scar dehiscence with underlying non‐adherent placenta is often challenging, even for PAS experts, both prenatally and intraoperatively. We investigated the use of standardized two‐dimensional grayscale ultrasound and Doppler imaging markers in ...
T. Adu‐Bredu, R. A. Aryananda, S. Mathewlynn, S. L. Collins   +3 more
wiley   +1 more source

Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre‐eclampsia

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 5, Page 620-625, November 2024.
ABSTRACT Objective To compare the diagnostic performance of different manufacturers' immunoassays for the soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio with that of a point‐of‐care (PoC) test for glycosylated fibronectin (GlyFn) in women with suspected pre‐eclampsia (PE).
I. Y. M. Wah, D. S. Sahota, N. K. L. Wong, N. M. W. Lee, C. J. Liu, C. S. L. Lau, H. H. Y. Leung, L. C. Poon   +7 more
wiley   +1 more source

Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 2, Page 187-192, August 2024.
ABSTRACT Objective To evaluate the relative importance of ethnicity and socioeconomic deprivation in determining the likelihood and prevalence of placentally derived composite of adverse pregnancy outcomes (CAPO) and composite of severe adverse pregnancy outcomes (CAPO‐S).
M. Minopoli, L. Noël, A. Dagge, G. Blayney, A. Bhide, B. Thilaganathan   +5 more
wiley   +1 more source

Research progress on early placental development in cattle(牛胎盘早期发育研究进展)

浙江大学学报. 农业与生命科学版
Pregnancy loss is a key issue limiting the sustainable development of cattle breeding, with about 50% occurring in the early stages of embryonic development, while abnormal placental development is a significant cause of early pregnancy loss.
LIN Haiwei(林海威), XU Xu(胥栩), ZHU Ge(朱阁), DAI Pengxiu(戴鹏秀), WANG Huanan(王华南), CHEN Chen(陈晨)   +5 more
doaj   +1 more source

Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction

Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 5, Page 605-612, May 2024.
ABSTRACT Objective Antenatal growth assessment using ultrasound aims to identify small fetuses that are at higher risk of perinatal morbidity and mortality. This study explored whether the association between suboptimal fetal growth and adverse perinatal outcome varies with different definitions of fetal growth restriction (FGR) and different weight ...
M. Mascherpa, C. Pegoire, A. Meroni, M. Minopoli, B. Thilaganathan, A. Frick, A. Bhide   +6 more
wiley   +1 more source